1.3.1.20 A-431 cell squamous cell carcinoma 675089 1.3.1.20 adenocarcinoma cell tumor from patients with gastric cancer 697571 1.3.1.20 adrenal gland - 349254 1.3.1.20 adrenal gland low activity 349239, 349240 1.3.1.20 brain low activity 349240 1.3.1.20 Caki-1 cell - 685913 1.3.1.20 Caki-dTub cell - 685913 1.3.1.20 carcinoma cell cisplatin-sensitive ovarian carcinoma cell line 2008 and its cisplatin-resistant variant 2008/C13* 656043 1.3.1.20 carcinoma cell human oral epidermal carcinoma cell line OEC-M1, enzyme expression is induced by pretreatment with hydroxychavicol 657392 1.3.1.20 carcinoma cell ovarian carcinoma cell A2780 and SKOV-3, cisplatin-sensitive and cisplatin-resistant cell 2008 and 2008/C13*, cervical carcinoma cell A431, germ-cell tumor Tera-2, lung adenocarcinoma cell Calu-6 655159 1.3.1.20 CL-3 cell lung cancer cell line, high expression of enzyme isoform DDH1 and enzyme CYP1A1, and high level of DNA-benzo[a]pyrene adducts 673371 1.3.1.20 CL1-1 cell lung cancer cell line, high expression of enzyme isoform DDH1 and enzyme CYP1A1, and high level of DNA-benzo[a]pyrene adducts 673371 1.3.1.20 digestive gland - 740358 1.3.1.20 gill - 740358 1.3.1.20 heart - 349254 1.3.1.20 heart low activity 349239 1.3.1.20 intestine - 286128, 349254 1.3.1.20 kidney - 286127, 286128, 349239, 349242, 349254, 349258, 686023 1.3.1.20 kidney proximal and distal tubules of the cortex, loop of Henle of the medulla 349237 1.3.1.20 lens - 286128, 349240, 349254, 686023 1.3.1.20 liver - 286128, 349238, 349239, 349241, 349244, 349245, 349247, 349250, 349251, 349252, 349253, 349254, 349255, 349256, 349257, 349259, 349261, 349262, 349263, 655321, 697571 1.3.1.20 liver cDNAs isolated from HepG2 hepatoma cell line 349260 1.3.1.20 liver low activity 349242 1.3.1.20 liver resected hepatocellular carcinoma 656885 1.3.1.20 lung - 349254 1.3.1.20 lung low activity 349239, 349240 1.3.1.20 lung lung cancer cell lines 673371 1.3.1.20 additional information not found in liver and kidney 686023 1.3.1.20 NCI-H1437 cell lung adenocarcinoma cell line 671358 1.3.1.20 NCI-H1684 cell lung adenocarcinoma cell line 671358 1.3.1.20 NCI-H2009 cell lung adenocarcinoma cell line 671358 1.3.1.20 NCI-H2087 cell lung adenocarcinoma cell line 671358 1.3.1.20 NCI-H2126 cell lung adenocarcinoma cell line 671358 1.3.1.20 NCI-H23 cell lung adenocarcinoma cell line 671358 1.3.1.20 non-small cell lung cancer cell - 687141 1.3.1.20 ovary - 673903 1.3.1.20 ovary cisplatin-sensitive ovarian carcinoma cell line 2008 and its cisplatin-resistant variant 2008/C13* 656043 1.3.1.20 spleen - 349254 1.3.1.20 testis - 349243, 349254 1.3.1.20 testis low activity 349239